A Single Ascending Dose of HRS-4029 in Healthy Subjects

Clinical trial NCT06905314 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06905314
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2025-04-01
Primary completion: 2025-10-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.